This compound is primarily used in the synthesis of nucleoside analogs, which are crucial in the development of antiviral and anticancer drugs. Its structure allows it to act as a building block in the creation of modified nucleosides, enhancing their stability and bioavailability. The tert-butyldimethylsilyl (TBDMS) group serves as a protecting group for the hydroxyl function, enabling selective reactions during the synthesis process. This chemical is particularly valuable in the production of antiviral agents targeting diseases such as HIV, hepatitis, and herpes, where modified nucleosides inhibit viral replication. Its application extends to research in biochemistry and molecular biology, where it aids in studying nucleic acid interactions and developing therapeutic molecules.